Supreme Cannabis Launches UK Investment Platform

Creating A Mainstream US CBD Market

The Supreme Cannabis Company, based out of Toronto, has announced it’s launching Supreme Heights, an investment platform for the U.K. and Europe.

The new platform, which will be based in London, will focus on strategic investments and opportunities in the CBD wellness and health space throughout the U.K. and Europe. The venture plans to help provide services to high-growth businesses that offer premium products in the space.

It will be a separate entity solely focused on CBD in those areas.

“Supreme Heights will benefit from Supreme Cannabis’ regulatory, product commercialization, supply chain, marketing and capital markets expertise and corporate support services,” the company said. “Supreme Cannabis’ management team has immense experience supporting health and wellness companies operating in Canada and international markets. Supreme Heights will draw on the Company’s experience launching premium brands.”

Navdeep Dhaliwal, CEO of Supreme Cannabis, said that the European market contains a unique opportunity.

“The rapidly evolving CBD markets in the U.K. and Europe present compelling investment opportunities given the promising environments for new health and wellness companies to establish differentiated brands and capture meaningful market share. Supreme Heights is positioned to quickly act on attractive opportunities and establish an early mover advantage in the space,” Dhaliwal said. “Supreme Heights will benefit from our experience launching some of the most premium cannabis brands in Canada and from the strong leadership and the deep industry connections of our U.K. partners. We look forward to driving value for Supreme Cannabis shareholders through this investment platform.”  

Patrick Morton, the co-founder of Cannabis Invest U.K., will serve as the CEO of Supreme Heights. He’s been working in the cannabis industry for several years, and has 13 years of experience in the capital markets industry, particularly in equity research analysis.

“Over the last three years, Supreme Cannabis has built and scaled its cannabis business in Canada, a country setting international standards for cannabis frameworks and regulations. With Supreme Cannabis, we have gained a valuable strategic partner with a top tier management team and highly developed corporate services,” Morton said. “With guidance from Supreme Cannabis, we intend to make targeted investments in wellness brands that provide exposure to value-add categories in the U.K. and Europe’s CBD market, including vaporizers, edibles and beverages, topicals and ancillary services. We are committed to positively contributing to this emerging industry and intend to support companies that share our standards for quality, sustainability and innovation.”